Article Versions Notes

Marretta AL, Di Lorenzo G, Ribera D, Cannella L, von Arx C, Bracigliano A, Clemente O, Tafuto R, Pizzolorusso A, Tafuto S. Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors. Pharmaceutics. 2021; 13(9):1522. https://doi.org/10.3390/pharmaceutics13091522

Marretta, Antonella Lucia, Giuseppe Di Lorenzo, Dario Ribera, Lucia Cannella, Claudia von Arx, Alessandra Bracigliano, Ottavia Clemente, Roberto Tafuto, Antonio Pizzolorusso, and Salvatore Tafuto. 2021. "Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors" Pharmaceutics 13, no. 9: 1522. https://doi.org/10.3390/pharmaceutics13091522

Marretta, A. L., Di Lorenzo, G., Ribera, D., Cannella, L., von Arx, C., Bracigliano, A., Clemente, O., Tafuto, R., Pizzolorusso, A., & Tafuto, S. (2021). Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors. Pharmaceutics, 13(9), 1522. https://doi.org/10.3390/pharmaceutics13091522